Vimarsana
Biggest News Aggregation in the World

Lars Westblade News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lars Westblade. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lars Westblade Today - Breaking & Trending Today

Gut fungus has long-term impact on the immunological response to severe COVID-19 | Health - Vimarsana News

Gut fungus has long-term impact on the immunological response to severe COVID-19 | Health

The study shows that specific gut-dwelling fungi thrive in COVID-19, leading to the disease's extreme inflammation and long-term changes in immune system. | Health

Gut fungi amplify inflammation in severe COVID-19 - Vimarsana News

Gut fungi amplify inflammation in severe COVID-19

Certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives this disease while also causing long-lasting changes in the immune system, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.

Study sheds light on role of gut fungi in severe COVID-19 and long COVID - Vimarsana News

Study sheds light on role of gut fungi in severe COVID-19 and long COVID

Certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives this disease while also causing long-lasting changes in the immune system, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.

Gut fungi's lasting impact on severe COVID-19 - Vimarsana News

Gut fungi's lasting impact on severe COVID-19

<p>Certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives this disease while also causing long-lasting changes in the immune system, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. This discovery identifies a group of patients who may benefit from specialized, but yet-to-be determined treatments.</p>

$750K awarded for intercampus research | Cornell Chronicle - Vimarsana News

$750K awarded for intercampus research | Cornell Chronicle

March 2, 2021 The Office of Academic Integration (OVPAI) has awarded $750,000 in seed grants to 10 studies ranging from refugee health and legal rights, to a vaccine treating fentanyl addiction and overdose, to pancreatic cancer and antibiotic tolerance. This year’s awardees represent faculty collaborations across five colleges and schools, and 18 departments and divisions across the Cornell Ithaca campus and Weill Cornell Medicine and Cornell Tech in New York City. Designed to catalyze collaborative research interactions among Cornell faculty based in Ithaca and New York City, OVPAI provid...